Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction — Stella

Home/Heart Failure With Preserved Ejection Fraction/Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure With Preserved Ejection Fraction trials

Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction

Trial locations(1 site)

China

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Key details

Sponsor

Chongqing Medical University

Enrollment target

~400 participants

Started

September 2020

Primary completion

June 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.